
News
- 
Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. 2022-04-29 Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. We are honored to invite the Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. GMP viral vector manufacturing facility.  Learn more 2022-04-29 Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. We are honored to invite the Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. GMP viral vector manufacturing facility.  Learn more
- 
TFBS received the official approval letter from US FDA for the pre-approval inspection (PAI) 2022-04-22 TFBS received the official approval letter from US FDA for the pre-approval inspection (PAI) The US FDA completed a pre-approval inspection (PAI) of TFBS Bioscience’ brand new GMP testing facility on April 22, 2022. No 483 observation is cited. The positive outcome adds further assurance for our newly-established GMP testing business.  Learn more 2022-04-22 TFBS received the official approval letter from US FDA for the pre-approval inspection (PAI) The US FDA completed a pre-approval inspection (PAI) of TFBS Bioscience’ brand new GMP testing facility on April 22, 2022. No 483 observation is cited. The positive outcome adds further assurance for our newly-established GMP testing business.  Learn more
-去背.png) 
           
             
           
             
           
             
           
  
 